{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:25:54Z","timestamp":1648790754478},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.therap.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T09:31:03Z","timestamp":1501752663000},"page":"665-668","source":"Crossref","is-referenced-by-count":0,"title":["Pour une utilisation optimale des associations fixes de m\u00e9dicaments"],"prefix":"10.1016","volume":"72","author":[{"given":"Gilles","family":"Bouvenot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Sassard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2017.07.003_bib0085","unstructured":"Caisse nationale de l\u2019Assurance maladie des travailleurs salari\u00e9s. Medic\u2019AM 2015 \u2013 Donn\u00e9es mensuelles et annuelles sur les m\u00e9dicaments rembours\u00e9s par l\u2019Assurance maladie. Ameli.fr [En ligne]. 2016. http:\/\/www.ameli.fr\/l-assurance-maladie\/statistiques-et-publications\/donnees-statistiques\/medicament\/medic-am\/medic-am-mensuel-2015.php [consult\u00e9 le 21\u00a0mars\u00a02017]."},{"issue":"9","key":"10.1016\/j.therap.2017.07.003_bib0090","first-page":"1","article-title":"Pourquoi autant d\u2019associations de m\u00e9dicaments antihypertenseurs sur le march\u00e9\u00a0?","volume":"21","author":"Drici","year":"2009","journal-title":"Sang Thrombose Vaisseaux"},{"key":"10.1016\/j.therap.2017.07.003_bib0095","series-title":"Associations th\u00e9rapeutiques fixes. Atouts, limites et perspectives","author":"Dievart","year":"2012"},{"issue":"2","key":"10.1016\/j.therap.2017.07.003_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03262454","article-title":"Fixed-dose combination therapy in hypertension: pros","volume":"19","author":"Taddei","year":"2012","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.therap.2017.07.003_bib0105","first-page":"967073","article-title":"The effect on treatment adherence of administering drugs as fixed-dose combinations versus as separate pills: systematic review and metaanalysis","author":"Van Galen","year":"2014","journal-title":"AIDS Res Treat"},{"issue":"8","key":"10.1016\/j.therap.2017.07.003_bib0110","doi-asserted-by":"crossref","first-page":"e6549","DOI":"10.5867\/medwave.2016.08.6549","article-title":"Fixed-dose versus separate drug combination for antihypertensive treatment: literature review","volume":"16","author":"Calleja Rivero","year":"2016","journal-title":"Medwave"},{"issue":"5","key":"10.1016\/j.therap.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/1753944713498638","article-title":"Management of hypertension with fixed-dose triple-combination treatments","volume":"7","author":"Epstein","year":"2013","journal-title":"Adv Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.therap.2017.07.003_bib0120","first-page":"34","article-title":"New therapies for arterial hypertension","volume":"58","author":"Pagliaro","year":"2016","journal-title":"Panminerva Med"},{"issue":"8","key":"10.1016\/j.therap.2017.07.003_bib0125","doi-asserted-by":"crossref","first-page":"e0161285","DOI":"10.1371\/journal.pone.0161285","article-title":"Free versus fixed combination antihypertensive therapy for essential arterial hypertension: a systematic review and meta-analysis","volume":"11","author":"Mallat","year":"2016","journal-title":"Plos One"},{"issue":"6, Cahier\u00a02","key":"10.1016\/j.therap.2017.07.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/S0181-5512(08)73691-X","article-title":"Int\u00e9r\u00eat des combinaisons fixes","volume":"31","author":"Lachkar","year":"2008","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"10.1016\/j.therap.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/ICU.0000000000000346","article-title":"New classes of glaucoma medications","volume":"28","author":"Schehlein","year":"2017","journal-title":"Curr Opin Ophtalmol"},{"key":"10.1016\/j.therap.2017.07.003_bib0140","series-title":"R\u00e8glement int\u00e9rieur de la Commission de la transparence. Annexe 3\u00a0Recommandation relative aux m\u00e9dicaments constitu\u00e9s d\u2019une association fixe de plusieurs principes actifs","year":"2017"},{"key":"10.1016\/j.therap.2017.07.003_bib0145","series-title":"Associations th\u00e9rapeutiques fixes","article-title":"Les combinaisons vaccinales. Une association th\u00e9rapeutique fixe tr\u00e8s particuli\u00e8re","author":"B\u00e9gu\u00e9","year":"2012"},{"issue":"2","key":"10.1016\/j.therap.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03262453","article-title":"Fixed-dose combination therapy in hypertension: cons","volume":"19","author":"Angeli","year":"2012","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"49","key":"10.1016\/j.therap.2017.07.003_bib0155","doi-asserted-by":"crossref","first-page":"e2229","DOI":"10.1097\/MD.0000000000002229","article-title":"Safety of fixed dose of antihypertensive drug combinations compared to (single pill) free-combinations: a nested matched case-control analysis","volume":"94","author":"Nowak","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.therap.2017.07.003_bib0080","series-title":"Exforge HCT\u00ae avis de la Commission de la transparence","year":"2012"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595717301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T20:27:31Z","timestamp":1569961651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595717301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0040595717301026"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2017.07.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}